Is This the New Playbook for Curing Rare Childhood Diseases?
A Sloan Fellow aims to cure pediatric cancer through an international consortium for collaborative drug research.
A Sloan Fellow aims to cure pediatric cancer through an international consortium for collaborative drug research.
Thousands of graduating students, alumni, and their families came to campus at the end of May for the 2024 commencement ceremonies and Reunion celebrations. Among the returning graduates were 1,404 Sloanies and their guests who attended MIT Sloan Reunion 2024.
Pablo Espuela, SFMBA ‘24, is a global business leader with expertise in digital business strategy, operations, and international affairs.
Several sessions at the 2024 MIT Sloan Reunion explored the use of AI in health care, entrepreneurship, tourism, and agriculture.
Tony Roa, SFMBA ’24, is a United States Navy submarine officer with 15 years’ experience leading teams of sailors in solving technical engineering challenges.
With a background in mechanical engineering, Matthew Howard, SFMBA ‘24 has spent the last decade in startups and scale-ups designing and manufacturing 5G infrastructure for the North American telecommunications industry.
Sarah Hosein is an executive coach with experience in healthcare and a member of the MIT SFMBA Class of 2024.
At milemark•capital, three Sloan Fellows MBA program alumni and their professor are investing in early-stage startups propelled by innovative founders and AI.
Bain & Company’s clients want to know how they can use generative AI (GenAI) to add value to their businesses. In order to make recommendations, Bain & Company Partner Jennifer Smith, MBA ’11, and Senior Manager Enrico Innocenti, MBA ’18, needed more information. They enlisted a team of six Prosemin...
In a new book, David Coghlan, SF ’85, reviews the nearly 70-year career of the late Edgar Schein, who mentored the author and many others in the MIT Sloan Fellows MBA Program.